News

Filter

Current filters:

USAOphthalmicsDaytrana

1 to 9 of 95918 results

Vifor’s Velphoro gains marketing authorization in the EU for hyperphosphatemia

Vifor’s Velphoro gains marketing authorization in the EU for hyperphosphatemia

27-08-2014

Switzerland-based iron deficiency specialist Vifor has received European Union marketing authorization…

Chronic kidney diseaseHyperphosphatemiaMedicineNephrologyNephrology and HepatologyPeritoneal dialysisPharmaceuticalRegulationRenal dialysisSwitzerlandVelphoroVifor Pharma

FDA backs added indication for GSK’s Promacta

FDA backs added indication for GSK’s Promacta

27-08-2014

The Food and Drug Administration has approved UK pharma giant GlaxoSmithKline’s supplemental New Drug…

GlaxoSmithKlineHematologyLigand PharmaceuticalsPharmaceuticalPromactaRare diseasesRegulationRevoladeUSA

Pfizer and Merck to explore potential of Xalkori/pembrolizumab combo

Pfizer and Merck to explore potential of Xalkori/pembrolizumab combo

26-08-2014

US pharma giants Pfizer and Merck & Co have inked an agreement to explore the therapeutic potential of…

Merck & CoOncologypembrolizumabPfizerPharmaceuticalResearchXalkori

Health Canada OKs Biogen Idec’s hemophilia A therapy Eloctate

Health Canada OKs Biogen Idec’s hemophilia A therapy Eloctate

26-08-2014

Canadian regulator Health Canada has approved US Biotech major Biogen Idec’s Eloctate (antihemophilic…

Biogen IdecBiotechnologyCanadaEloctateHematologyRegulationSwedish Orphan Biovitrum

Recipharm inks deal with Isofol Medical on Modufolin

Recipharm inks deal with Isofol Medical on Modufolin

26-08-2014

Swedish contract development and manufacturing group Recipharm and Isofol Medical AB, a Gothenburg-based…

FinancialIsofol MedicalModufolinOncologyPharmaceuticalProductionRecipharmResearch

Concert Pharmaceuticals achieves $2 million milestone for its AVP-786

Concert Pharmaceuticals achieves $2 million milestone for its AVP-786

26-08-2014

USA-based Concert Pharmaceuticals has achieved a $2 million milestone under its development and license…

Avanir PharmaceuticalsAVP-786Concert PharmaceuticalsMajor depressive disorderMedicineNeurochemistryNeurologicalPharmaceuticalPharmacologyResearchTreatment of major depressive disorderUSA

Lysosomal storage disorders are a particularly lucrative corner of ultra-orphan market

Lysosomal storage disorders are a particularly lucrative corner of ultra-orphan market

26-08-2014

A new report by Thomson Reuters has highlighted the economic power of ultra-orphan diseases, the informal…

GenzymeGenzymeLysosomal storage disordersMedicinePharmaceuticalRare diseasesRare inherited metabolic disordersResearchThomson ReutersTreatment for lysosomal storage disordersUltra-orphan diseases

Advaxis and Merck & Co collaborate on prostate cancer

Advaxis and Merck & Co collaborate on prostate cancer

26-08-2014

US cancer immunotherapies firm Advaxis has entered into a clinical trial collaboration agreement with…

AdvaxisADXS-PSABiotechnologyLicensingMerck & CoOncologypembrolizumabResearch

1 to 9 of 95918 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top